Page 607«..1020..606607608609..620630..»

Pennsylvania Biotechnology Center Responsible for 573 Jobs and $579 Million – Business Wire (press release)

By Dr. Matthew Watson


CBS Local
Pennsylvania Biotechnology Center Responsible for 573 Jobs and $579 Million
Business Wire (press release)
DOYLESTOWN, Pa.--(BUSINESS WIRE)--The Pennsylvania Biotechnology Center, in Doylestown, Pa., managed and established by the Hepatitis B Foundation in 2006 and co-owned with Delaware Valley College, proudly unveils a 2013 Economic Impact ...
Biotech Center In Philadelphia Suburb Generating Millions For Local EconomyCBS Local

all 2 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHddXIK3KqRY2xV_v91Ua1WJcSdYw&url=http://www.businesswire.com/news/home/20130308005016/en/Pennsylvania-Biotechnology-Center-Responsible-573-Jobs-579

To Read More: Pennsylvania Biotechnology Center Responsible for 573 Jobs and $579 Million – Business Wire (press release)
categoriaUncategorized commentoComments Off on Pennsylvania Biotechnology Center Responsible for 573 Jobs and $579 Million – Business Wire (press release) | dataMarch 10th, 2013
Read All

Women in biotechnology: Barred from the boardroom – Nature.com

By Dr. Matthew Watson


Nature.com
Women in biotechnology: Barred from the boardroom
Nature.com
Vicki Sato, a professor of biology and management at Harvard with a long career in the biotechnology industry, says she could not believe what she was seeing. “I was stunned by the sampling she had done, and told her she had to be wrong,” says Sato.

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGtG2Hv3jrqUjvD6gmmAopodLjJNA&url=http://www.nature.com/news/women-in-biotechnology-barred-from-the-boardroom-1.12546

To Read More: Women in biotechnology: Barred from the boardroom – Nature.com
categoriaUncategorized commentoComments Off on Women in biotechnology: Barred from the boardroom – Nature.com | dataMarch 10th, 2013
Read All

DuPont Pioneer and Mendel Biotechnology, Inc. Collaborate to Improve Water … – PR Web (press release)

By Dr. Matthew Watson


PR Web (press release)
DuPont Pioneer and Mendel Biotechnology, Inc. Collaborate to Improve Water ...
PR Web (press release)
DuPont Pioneer and Mendel Biotechnology, Inc., have entered into a license collaboration to evaluate and commercialize new gene leads for increased water use efficiency (WUE) and improved photosynthesis in corn. Under the agreement, DuPont Pioneer ...

and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGotlG5LG2moKAiW5S4XBw6Pd1r_A&url=http://www.prweb.com/releases/dupont_pioneer_seed/mendel_biotechnology/prweb10509060.htm

To Read More: DuPont Pioneer and Mendel Biotechnology, Inc. Collaborate to Improve Water … – PR Web (press release)
categoriaUncategorized commentoComments Off on DuPont Pioneer and Mendel Biotechnology, Inc. Collaborate to Improve Water … – PR Web (press release) | dataMarch 10th, 2013
Read All

Ethical Aspects Of Biotechnology – Mondaq News Alerts (registration)

By Dr. Matthew Watson

Ethical Aspects Of Biotechnology
Mondaq News Alerts (registration)
BIOTECHNOLOGY in turn, taking one of its numberless definitions, is any technological application which uses biological systems, living beings or those derived from the latter, in order to produce or modify products or processes for a specific purpose.

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHrV1aaB3uDstYcTy-GXKe-cc_VBg&url=http://www.mondaq.com/x/225716/Life%2BSciences%2BBiotechnology/Ethical%2BAspects%2BOf%2BBiotechnology

To Read More: Ethical Aspects Of Biotechnology – Mondaq News Alerts (registration)
categoriaUncategorized commentoComments Off on Ethical Aspects Of Biotechnology – Mondaq News Alerts (registration) | dataMarch 10th, 2013
Read All

Casino developer dabbles in energy production, biotechnology and palm oil crops – VEGAS INC

By Dr. Matthew Watson


VEGAS INC
Casino developer dabbles in energy production, biotechnology and palm oil crops
VEGAS INC
KT Lim, chairman/CEO of the Genting Group speaks during a news conference at Steelman Design Monday, March 4, 2013. The Genting Group announced plans for Resorts World Las Vegas, a multi-billion dollar resort to be built on the site of the stalled ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGyq40RUc1ImQsG70n01qc-8en3Ig&url=http://www.vegasinc.com/news/2013/mar/05/casino-developer-dabbles-energy-production-biotech/

To Read More: Casino developer dabbles in energy production, biotechnology and palm oil crops – VEGAS INC
categoriaUncategorized commentoComments Off on Casino developer dabbles in energy production, biotechnology and palm oil crops – VEGAS INC | dataMarch 10th, 2013
Read All

BioChain licenses Epigenomics’ methylated Septin9 marker for blood based … – pharmabiz.com

By Dr. Matthew Watson

BioChain licenses Epigenomics' methylated Septin9 marker for blood based ...
pharmabiz.com
BioChain is a manufacturer of Life Sciences tools and the pioneer of molecular genetics diagnostics in the US and China. It is also the owner and operator of an independent reference laboratory, equivalent of a CLIA lab, in China – Beijing BioChain ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGrz6IyLSTDTm8xgdSDpBNWQLYUYg&url=http://www.pharmabiz.com/NewsDetails.aspx?aid%3D74203%26sid%3D2

To Read More: BioChain licenses Epigenomics’ methylated Septin9 marker for blood based … – pharmabiz.com
categoriaUncategorized commentoComments Off on BioChain licenses Epigenomics’ methylated Septin9 marker for blood based … – pharmabiz.com | dataMarch 10th, 2013
Read All

Largest study of salmon health ever undertaken set to begin in BC – Globe and Mail

By Dr. Matthew Watson


Globe and Mail
Largest study of salmon health ever undertaken set to begin in BC
Globe and Mail
Now Dr. Miller, the groundbreaking head of molecular genetics for Fisheries and Oceans Canada, and Brian Riddell, a former top scientist with DFO who directs the non-profit Pacific Salmon Foundation, are teaming up with Genome B.C. in the most ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGqmepJLUcne_kBgzCX20tp2D5YPQ&url=http://www.theglobeandmail.com/news/british-columbia/largest-study-of-salmon-health-ever-undertaken-set-to-begin-in-bc/article9563287/?cmpid%3Drss1

To Read More: Largest study of salmon health ever undertaken set to begin in BC – Globe and Mail
categoriaUncategorized commentoComments Off on Largest study of salmon health ever undertaken set to begin in BC – Globe and Mail | dataMarch 10th, 2013
Read All

The Cell’s Inner Compass: Texas A&M Study Identifies Key Mediators Of … – Texas A&M University

By Dr. Matthew Watson


Texas A&M University
The Cell's Inner Compass: Texas A&M Study Identifies Key Mediators Of ...
Texas A&M University
“Using a combination of molecular genetics, cell biology and advanced imaging techniques, we showed that Nck adaptors are key components of the molecular machinery that coordinates intrinsic cell directionality. Nck adaptors modify the actin ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEf-WqyW5q7ofUi6Rk2WaVS0MrzHw&url=http://tamutimes.tamu.edu/2013/03/08/the-cells-inner-compass-texas-am-study-identifies-key-mediators-of-directional-cell-migration/

To Read More: The Cell’s Inner Compass: Texas A&M Study Identifies Key Mediators Of … – Texas A&M University
categoriaUncategorized commentoComments Off on The Cell’s Inner Compass: Texas A&M Study Identifies Key Mediators Of … – Texas A&M University | dataMarch 10th, 2013
Read All

“The Healing Cell” touts enormous success using adult stem cells – National Right to Life News

By Dr. Matthew Watson


National Right to Life News
“The Healing Cell” touts enormous success using adult stem cells
National Right to Life News
Dr. David Prentice, Adjunct Professor of Molecular Genetics and an international expert on the stem cell topic, recently testified several times to Kansas lawmakers on this developing field. Prentice quoted recent science and medical journals ...

and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEh8l-hGB4Ctne89CnZhqVT0wzfGg&url=http://www.nationalrighttolifenews.org/news/2013/03/the-healing-cell-touts-enormous-success-using-adult-stem-cells/

To Read More: “The Healing Cell” touts enormous success using adult stem cells – National Right to Life News
categoriaUncategorized commentoComments Off on “The Healing Cell” touts enormous success using adult stem cells – National Right to Life News | dataMarch 10th, 2013
Read All

Public Banned from ‘Best Stem Cell Meeting in the World’

By Dr. Matthew Watson

“The best stem cell meeting in the
world” is underway today in San Francisco – conducted at taxpayer
expense – but the public is barred from attending.

More than 500 persons are at the meeting at an undisclosed location, including some
representatives of biotech firms. And the meeting is even being
written about on the internet by a blogger. But the $3 billion
California stem cell agency says the public is not allowed in because
some of the information is “proprietary.”
CIRM President Alan Trounson addressed
the meeting earlier this week and declared it was “the best stem
cell meeting in the world,” according to UC Davis researcher Paul
Knoepfler
, who is reporting from the session on his blog.
The attendees consist almost entirely
of the recipients of taxpayer-funded grants given by the stem cell agency  although a number of
businesses have been brought in.. CIRM, which is paying for the gathering,  says of the annual sessions,

 “The purpose of meeting is to bring together investigators funded
by CIRM, to highlight their research, and encourage scientific
exchange and collaboration.”

Kevin McCormack, spokesman for the
agency, today said the public was barred from the meeting, which ends tomorrow, because “so
many presentations/talks (are) using proprietary information.”
That rationale is nothing new in the
world of science. But there is no chance of maintaining secrecy about anything that is
truly proprietary when hundreds of people have access to it in
this sort of forum. No penalties exist for disclosure, plus the whole
point of the session is to share information.
Yesterday we wrote briefly about the importance of transparency and openness in government, and make no mistake about
it, the stem cell agency is a government operation. We doubt that
anything egregious is underway at the session, but closing it to the
public is a reminder about where the agency's priorities lie.  

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/uiwodYaNIP8/public-banned-from-best-stem-cell.html

To Read More: Public Banned from ‘Best Stem Cell Meeting in the World’
categoriaStem Cell Therapy commentoComments Off on Public Banned from ‘Best Stem Cell Meeting in the World’ | dataMarch 10th, 2013
Read All

Good News, Bad News and the California Stem Cell Agency

By Dr. Matthew Watson

A few weeks ago an anonymous reader
admonished the California Stem Cell Report to be more positive about
the $3 billion agency and its efforts to develop the cures that its
backers promised California voters more than eight years ago.

The comment was thoughtful and pointed
out that “almost all the time” the agency “has done the right
thing.” The reader made the remarks in the context of continuing
coverage of the Institute of Medicine (IOM) report that found there
were major flaws in CIRM's operations. (The reader's comment can be found here at the end of the post.)
Given the reader's remarks, it seems a
good time to review the operating principles and biases of the
California Stem Cell Report.
Bias No. 1: Openness and transparency
come first in any government operation. They are
fundamental to the integrity of all government enterprises. Bias No.
2: The California stem cell agency is generally doing a good job at
funding stem cell research. We generally favor all manner of stem cell research. 
Regarding our operating principles, the
goal is report news and information about the agency along with
analysis and explanation. One key to understanding what this blog
does is to understand what news is. News by definition is almost
always “bad” as opposed to “good.” News deals with the
exceptional. It is not news that millions of drivers commute to work
safely each day on California freeways. It is news when one is killed
in a traffic accident.
The California Stem Cell Report also
tries to fill information voids. We understand that the stem cell
agency believes certain information is not in their best interests to
disclose. Such is always the case with both private and public
organizations. However, it is generally in the public interest to see
more information rather less, particularly information that an
organization would rather not see become public.
Analysis and explanation of what the stem cell agency does is rare in the California media and even less seen
nationally or internationally. This blog focuses primarily on the
public policy aspects of the agency – not the science. The agency
is an unprecedented experiment that brings together big science, big
government, big academia, big business, religion, morality, ethics,
life and death in single enterprise – one that operates outside the
normal constraints of state agencies. No governor can cut CIRM's
budget. Nor can the legislature. Even tiny changes in Proposition 71,
which created CIRM, require either another vote of the people or the
super, super-majority vote of both houses of the legislature and the signature of the governor. All of
this is the result of the initiative process – a well-intended tool
that has been abused and that has also created enormous problems for the
state of California that go well beyond the stem cell agency.
Then there is the funding of the
agency, which basically lives off the state's credit card. All the
money that goes for grants is borrowed and roughly doubles the actual
expense to taxpayers.
Since January 2005, we have posted
3,452 items on the stem cell agency because we believe the California
Institute for Regenerative Medicine (CIRM)
is an important enterprise
– one that deserves more attention that it receives in the
mainstream media. Our readership includes persons at the NIH, the
National Academy of Sciences, most of the major stem cell research
centers in California, academic institutions in the Great Britain,
Canada, Norway, Germany, Russia, China, Australia, Singapore and
Korea – not to mention the agency itself and scientific journals.
We do not attempt to replicate what the
California stem cell agency itself does, which is to post online a
prodigious amount of positive stories and good news about the agency.
To do so would serve no useful public purpose and would simply be
repetitive. That said, there is room to acknowledge the work that the
agency does, particularly the staff, but also the board. We try to
point that out from time to time.
The California Stem Cell Report also
welcomes and encourages comments, anonymous and otherwise. Directors
and executives of the agency have a standing invitation to comment at
length and have their remarks published verbatim, something almost
never seen in the mainstream media.
Finally, given the questions raised by
the Institute of Medicine about disclosure of potential conflicts of
interests, the author of this blog and his immediate family have no
financial interests in any biotech or stem cell companies, other than
those that may be held by large mutual funds. We have no relatives
working in the field. We do have the potential personal conflicts,
cited generally by the IOM in connection with some CIRM board
members, involving relatives who have afflictions that could be
possibly be treated with stem cell therapies in the distant future.   

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/GRJeamu0RXw/good-news-bad-news-and-california-stem.html

To Read More: Good News, Bad News and the California Stem Cell Agency
categoriaStem Cell Therapy commentoComments Off on Good News, Bad News and the California Stem Cell Agency | dataMarch 10th, 2013
Read All

BBSRC attends UK Biotechnology showcase – Labmate Online

By Dr. Matthew Watson

BBSRC attends UK Biotechnology showcase
Labmate Online
At a recent showcase about the success and future of Industrial Biotechnology (IB) in the UK, David Willetts, Minister for Universities and Science, announced £35M of BBSRC funding to boost research in IB and Bioenergy. The funding will create networks ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF5hz3y4qrDaqtqg7IKlmMGFDMDXw&url=http://www.labmate-online.com/news/news-and-views/5/bbsrc/bbsrc_attends_uk_biotechnology_showcase_/24170/

To Read More: BBSRC attends UK Biotechnology showcase – Labmate Online
categoriaUncategorized commentoComments Off on BBSRC attends UK Biotechnology showcase – Labmate Online | dataMarch 10th, 2013
Read All

East Bay Conversations: The Promises and Perils of Biotechnology – Berkeleyside

By Dr. Matthew Watson

East Bay Conversations: The Promises and Perils of Biotechnology
Berkeleyside
This event series features an impressive line-up of national and international speakers in conversation with local hosts and audience members on the regional an global implications of biotechnological development. The series launch on March 21st ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNES5tpYAQoMzhhSo9TVWEiZZJ722Q&url=http://www.berkeleyside.com/BerkeleysideCalendar/events/index.php?com%3Ddetail%26eID%3D9281

To Read More: East Bay Conversations: The Promises and Perils of Biotechnology – Berkeleyside
categoriaUncategorized commentoComments Off on East Bay Conversations: The Promises and Perils of Biotechnology – Berkeleyside | dataMarch 9th, 2013
Read All

Discgenics Successfully Completes Pilot Efficacy Study of Injectable Discosphereâ„¢ Cell Therapy

By Sykes24Tracey

SALT LAKE CITY, Feb. 28, 2013 /PRNewswire/ --Discgenics announces the successful completion of an animal study demonstrating safety and efficacy of its novel therapy for reducing back pain caused by degenerative disc disease. This product, known as Injectable Discosphere Cell Therapy (IDCT), features Discgenics' patented, allogeneic, human disc-derived stem cell technology. The study showed that after one injection of IDCT in degenerated discs there was a restoration of disc height and tissue architecture, while noting no inflammatory response.

Discgenics CEO Flagg Flanagan said, " We are very encouraged by the results of the small animal pilot study as it shows the initial safety and efficacy of IDCT, which is produced from adult human disc-derived stem cells.We are optimistic that these early results will be indicative of our therapy's performance in further animal studies and will accelerate us toward human clinical studies and, ultimately, to an FDA cleared product.We believe this technology will revolutionize the way back pain is treated." Discgenics is currently conducting further studies of safety and efficacy in multiple animal species to support future scientific publications and for use in gaining regulatory clearance.

About Discgenics, Inc.

Discgenics is a privately funded spinal therapeutics company that is utilizing adult human disc stem cells within a tissue engineering approach to treat patients debilitated by degenerative disc disease. News and other information on the company are available at: http://www.discgenics.com.

Read more:
Discgenics Successfully Completes Pilot Efficacy Study of Injectable Discosphereâ„¢ Cell Therapy

To Read More: Discgenics Successfully Completes Pilot Efficacy Study of Injectable Discosphereâ„¢ Cell Therapy
categoriaUncategorized commentoComments Off on Discgenics Successfully Completes Pilot Efficacy Study of Injectable Discosphereâ„¢ Cell Therapy | dataMarch 3rd, 2013
Read All

Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy – Video

By daniellenierenberg


Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy
Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy He is a known case of Myotonic MD with history of gradual onset of progressive lower extremities muscle weakness since age of 25 years. He also has history of delayed milestones. His weakness is progressive in nature. He falls while walking so walks with human support only. He has complaints of early fatigue and slurred speech due to tongue hypertrophy. He has atrophy of proximal muscles of all extremities. He has modified independence in almost all ADL. Neurologically, hypotonic, hyporeflexic. On examination: lower limb distal muscles are 0/5 on MMT while proximal muscles are having 2++/5 on MMT. Upper extremities left side proximal muscles are 1++/5 while right side proximal muscles are 3 #713;/5, distal muscles are 3++/5 in upper extremities. Functionally, modified independence in all ADL. On FIM he scores 99. After Stem Cell Treatment 1. His face looks more fresh. 2. His neck used to fall back previously but now he can control his neck well in each movement. 3. Back muscle strength has improved. 4. Bridging is better now. He can lift his back more up now which he couldn #39;t do at all. 5. His stamina has improved. 6. His shoulder strength has improved. Shoulder shrugging is better now. Active shoulder flexion, range of motion is more now. 7. Side lying to sitting he can do without any support which was not possible before. 8. Drooling of saliva from mouth in night is completely stopped. 9. His legs used ...

By: neurogenbsi

Visit link:
Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy - Video

To Read More: Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy – Video
categoriaUncategorized commentoComments Off on Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy – Video | dataMarch 3rd, 2013
Read All

Myotonic Muscular Dystrophy Before and After Stem Cell Therapy – Video

By Sykes24Tracey


Myotonic Muscular Dystrophy Before and After Stem Cell Therapy
Myotonic Muscular Dystrophy Improvement in a week after Stem Cell Therapy He is a known case of Myotonic MD with history of gradual onset of progressive lower extremities muscle weakness since age of 25 years. He also has history of delayed milestones. His weakness is progressive in nature. He falls while walking so walks with human support only. He has complaints of early fatigue and slurred speech due to tongue hypertrophy. He has atrophy of proximal muscles of all extremities. He has modified independence in almost all ADL. Neurologically, hypotonic, hyporeflexic. On examination: lower limb distal muscles are 0/5 on MMT while proximal muscles are having 2++/5 on MMT. Upper extremities left side proximal muscles are 1++/5 while right side proximal muscles are 3 #713;/5, distal muscles are 3++/5 in upper extremities. Functionally, modified independence in all ADL. On FIM he scores 99. After Stem Cell Treatment 1. His face looks more fresh. 2. His neck used to fall back previously but now he can control his neck well in each movement. 3. Back muscle strength has improved. 4. Bridging is better now. He can lift his back more up now which he couldn #39;t do at all. 5. His stamina has improved. 6. His shoulder strength has improved. Shoulder shrugging is better now. Active shoulder flexion, range of motion is more now. 7. Side lying to sitting he can do without any support which was not possible before. 8. Drooling of saliva from mouth in night is completely stopped. 9. His legs used ...

By: neurogenbsi

Visit link:
Myotonic Muscular Dystrophy Before and After Stem Cell Therapy - Video

To Read More: Myotonic Muscular Dystrophy Before and After Stem Cell Therapy – Video
categoriaUncategorized commentoComments Off on Myotonic Muscular Dystrophy Before and After Stem Cell Therapy – Video | dataMarch 3rd, 2013
Read All

Cerebral Palsy Before and After Stem Cell Therapy Comparison – Video

By Sykes24Tracey


Cerebral Palsy Before and After Stem Cell Therapy Comparison
Cerebral Palsy Before and After Stem Cell Therapy Comparison video Stem Cell Therapy done at Dr Alok Sharma NeuroGen Brain and Spine Institute Surana Sethia Hospital Sion-Trombay Rd, Suman Ngr Opp Corporate Park, Chembur, Mumbai -- 71. Tel : 022 - 25283706, 022 - 25281610, Mob : +91 9920 200 400 http://www.neurogen.in http://www.stemcellsmumbai.com

By: neurogenbsi

See the original post:
Cerebral Palsy Before and After Stem Cell Therapy Comparison - Video

To Read More: Cerebral Palsy Before and After Stem Cell Therapy Comparison – Video
categoriaUncategorized commentoComments Off on Cerebral Palsy Before and After Stem Cell Therapy Comparison – Video | dataMarch 3rd, 2013
Read All

Stem Cell Therapy for Autism Part 2 – Video

By NEVAGiles23


Stem Cell Therapy for Autism Part 2
He is a known case of Autism with history of full term caesarean section delivery and cried immediately after birth with near normal motor milestones. But as he was put in school, there were regular complaints of him being hyperactive. He was then diagnosed to have Autism. He was shifted to special school then. Neurologically, he has near normal tone, reflexes and muscle power. On examination: he has hyperactivity. He has aggressive behaviour with episodes of violence and beating others. He has repetitive speech (echolalia), but it is need based. He has social isolation. He is bowel bladder trained. He is independent in most ADL. Functionally, he needs supervision in most ADL. On FIM he scores 106. After Stem Cell Therapy Psychology assessment: 1) Now his duration of expressing his anger has reduced (ie) previously he would get angry and it would continue for half an hour to 20 minutes. Now it has reduced to 10 minutes. 2) Now his level of understanding and tolerance level has increased (ie) before he would get upset even before his parents spoke whereas now he listens to them and follows commands. 3) Now he has started writing (ie) now he can copy from the book and he can do so for a duration of ½ hour to 1 hour which wasn #39;t possible at all before. 4) Previously he had obsessive features like washing his hands repetitively but now it has reduced. 5) Previously he would disturb others in the classroom by shouting or sitting next to them but now he doesn #39;t disturb others ...

By: neurogenbsi

See the article here:
Stem Cell Therapy for Autism Part 2 - Video

To Read More: Stem Cell Therapy for Autism Part 2 – Video
categoriaUncategorized commentoComments Off on Stem Cell Therapy for Autism Part 2 – Video | dataMarch 3rd, 2013
Read All

Stem Cell Therapy for Autism Part 1 – Video

By raymumme


Stem Cell Therapy for Autism Part 1
He is a known case of Autism with history of full term caesarean section delivery and cried immediately after birth with near normal motor milestones. But as he was put in school, there were regular complaints of him being hyperactive. He was then diagnosed to have Autism. He was shifted to special school then. Neurologically, he has near normal tone, reflexes and muscle power. On examination: he has hyperactivity. He has aggressive behaviour with episodes of violence and beating others. He has repetitive speech (echolalia), but it is need based. He has social isolation. He is bowel bladder trained. He is independent in most ADL. Functionally, he needs supervision in most ADL. On FIM he scores 106. After Stem Cell Therapy 1. Angry spells are short lasting than before. Earlier, if he used to be upset for half hour at a stretch, now he calms down in 2 minutes. 2. Did not ask for toothpaste for second time which he used to do daily. 3. He does not insist on bathing 2-3 times a day like before. Now, he takes bath once a day. 4. Visits washroom once in 2-3 hours and then washes his hand normally and leaves the washroom. Earlier, he used to go to washroom every hourly and wash his hand, spill water on his clothes and arms. 5. Eye contact attention span improved. 6. Sitting tolerance improved and attends for 30 mins session. 7. Listening skills and observation skills on demand improved. 8. Screaming behavior reduces when given paper tearing activity. 9. His parents feel his ...

By: neurogenbsi

More:
Stem Cell Therapy for Autism Part 1 - Video

To Read More: Stem Cell Therapy for Autism Part 1 – Video
categoriaUncategorized commentoComments Off on Stem Cell Therapy for Autism Part 1 – Video | dataMarch 3rd, 2013
Read All

Stem Cell Therapy for Autism Part 1 Tamil – Video

By NEVAGiles23


Stem Cell Therapy for Autism Part 1 Tamil
He is a known case of Autism with history of full term caesarean section delivery and cried immediately after birth with near normal motor milestones. But as he was put in school, there were regular complaints of him being hyperactive. He was then diagnosed to have Autism. He was shifted to special school then. Neurologically, he has near normal tone, reflexes and muscle power. On examination: he has hyperactivity. He has aggressive behaviour with episodes of violence and beating others. He has repetitive speech (echolalia), but it is need based. He has social isolation. He is bowel bladder trained. He is independent in most ADL. Functionally, he needs supervision in most ADL. On FIM he scores 106. After Stem Cell Therapy 1. Angry spells are short lasting than before. Earlier, if he used to be upset for half hour at a stretch, now he calms down in 2 minutes. 2. Did not ask for toothpaste for second time which he used to do daily. 3. He does not insist on bathing 2-3 times a day like before. Now, he takes bath once a day. 4. Visits washroom once in 2-3 hours and then washes his hand normally and leaves the washroom. Earlier, he used to go to washroom every hourly and wash his hand, spill water on his clothes and arms. 5. Eye contact attention span improved. 6. Sitting tolerance improved and attends for 30 mins session. 7. Listening skills and observation skills on demand improved. 8. Screaming behavior reduces when given paper tearing activity. 9. His parents feel his ...

By: neurogenbsi

See the article here:
Stem Cell Therapy for Autism Part 1 Tamil - Video

To Read More: Stem Cell Therapy for Autism Part 1 Tamil – Video
categoriaUncategorized commentoComments Off on Stem Cell Therapy for Autism Part 1 Tamil – Video | dataMarch 3rd, 2013
Read All

Page 607«..1020..606607608609..620630..»


Copyright :: 2025